HUP0300738A2 - Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts - Google Patents

Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts

Info

Publication number
HUP0300738A2
HUP0300738A2 HU0300738A HUP0300738A HUP0300738A2 HU P0300738 A2 HUP0300738 A2 HU P0300738A2 HU 0300738 A HU0300738 A HU 0300738A HU P0300738 A HUP0300738 A HU P0300738A HU P0300738 A2 HUP0300738 A2 HU P0300738A2
Authority
HU
Hungary
Prior art keywords
peptide salts
peptide
lhrh
producing
pharmaceutical preparations
Prior art date
Application number
HU0300738A
Other languages
Hungarian (hu)
Inventor
Horst Bauer
Michael Damm
Jürgen Engel
Waldemar Salonek
Gabriele Stach
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0300738(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of HUP0300738A2 publication Critical patent/HUP0300738A2/en
Publication of HUP0300738A3 publication Critical patent/HUP0300738A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Preparation of a peptide acid addition salt (I) comprises: (a) reacting a starting acid addition salt (II) of a basic peptide with a mixed bed ion exchanger (or a mixture of acidic and basic ion exchangers) in presence of a diluent; (b) reacting the obtained free basic peptide with an inorganic or organic acid to give (I); and (c) removing the diluent. Independent claims are included for: (i) (I) obtained by the process (specifically in lyophilized form); (ii) a pharmaceutical preparation containing (I) obtained by the process, together with auxiliaries, carriers and/or structuring agents; and (iii) the production of a preparation as in (ii), by adding the auxiliaries, carriers and/or structuring agents at least partially before removing the solvent.
HU0300738A 2000-08-17 2001-08-09 Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts HUP0300738A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (en) 2000-08-17 2000-08-17 Salts of biologically active peptides, their production and use
PCT/EP2001/009219 WO2002014347A2 (en) 2000-08-17 2001-08-09 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (2)

Publication Number Publication Date
HUP0300738A2 true HUP0300738A2 (en) 2003-09-29
HUP0300738A3 HUP0300738A3 (en) 2004-08-30

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300738A HUP0300738A3 (en) 2000-08-17 2001-08-09 Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts

Country Status (30)

Country Link
US (1) US6780972B2 (en)
EP (1) EP1309607B1 (en)
JP (1) JP2004506647A (en)
CN (1) CN1187369C (en)
AR (1) AR030371A1 (en)
AT (1) ATE280779T1 (en)
AU (2) AU1043902A (en)
BG (1) BG107612A (en)
BR (1) BR0113296A (en)
CA (1) CA2355573A1 (en)
CZ (1) CZ2003688A3 (en)
DE (2) DE10040700A1 (en)
DK (1) DK1309607T3 (en)
EE (1) EE200300065A (en)
ES (1) ES2230371T3 (en)
HK (1) HK1058366A1 (en)
HU (1) HUP0300738A3 (en)
IL (1) IL154150A0 (en)
MX (1) MXPA03001448A (en)
NO (1) NO20030618L (en)
NZ (1) NZ524023A (en)
PL (1) PL204496B1 (en)
PT (1) PT1309607E (en)
RU (1) RU2266296C2 (en)
SI (1) SI1309607T1 (en)
SK (1) SK3032003A3 (en)
TW (1) TWI236910B (en)
UA (1) UA74005C2 (en)
WO (1) WO2002014347A2 (en)
ZA (1) ZA200300777B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (en) * 2004-12-22 2006-06-28 Zentaris GmbH Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament
RU2525661C2 (en) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Method of obtaining high-titre antimicrobial serum for estimation of antigen activity of anti-staphylococcal vaccines
CN107056894B (en) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 Method for solid-phase synthesis of ganirelix acetate by fragment method
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800B (en) * 2020-09-22 2024-07-26 深圳市星银医药有限公司 Preparation method of pamoic acid polypeptide drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
EP0041286B1 (en) * 1980-06-02 1984-08-15 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (en) * 1993-02-19 1994-08-25 Asta Medica Ag New manufacturing process for Cetrorelix lyophilisate
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
DE4342092B4 (en) * 1993-12-09 2007-01-11 Zentaris Gmbh Long-acting suspension for injection and method of preparation
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
SK10272000A3 (en) * 1998-01-16 2001-01-18 Takeda Chemical Industries, Ltd. Sustained release compositions, process for producing the same and utilization thereof

Also Published As

Publication number Publication date
CN1447817A (en) 2003-10-08
WO2002014347A3 (en) 2002-08-08
DE10040700A1 (en) 2002-02-28
NO20030618D0 (en) 2003-02-07
RU2003107560A (en) 2005-01-27
EE200300065A (en) 2004-12-15
SK3032003A3 (en) 2004-05-04
BR0113296A (en) 2003-07-15
PL359495A1 (en) 2004-08-23
DE50104316D1 (en) 2004-12-02
WO2002014347A2 (en) 2002-02-21
AU2002210439B2 (en) 2005-10-20
BG107612A (en) 2003-12-31
HUP0300738A3 (en) 2004-08-30
US6780972B2 (en) 2004-08-24
SI1309607T1 (en) 2005-02-28
MXPA03001448A (en) 2004-12-13
US20020198146A1 (en) 2002-12-26
ATE280779T1 (en) 2004-11-15
CN1187369C (en) 2005-02-02
JP2004506647A (en) 2004-03-04
ZA200300777B (en) 2003-09-18
IL154150A0 (en) 2003-07-31
CA2355573A1 (en) 2003-02-22
RU2266296C2 (en) 2005-12-20
DK1309607T3 (en) 2005-01-17
EP1309607A2 (en) 2003-05-14
EP1309607B1 (en) 2004-10-27
CZ2003688A3 (en) 2004-03-17
NO20030618L (en) 2003-02-07
TWI236910B (en) 2005-08-01
NZ524023A (en) 2004-11-26
PT1309607E (en) 2005-02-28
PL204496B1 (en) 2010-01-29
ES2230371T3 (en) 2005-05-01
AR030371A1 (en) 2003-08-20
UA74005C2 (en) 2005-10-17
HK1058366A1 (en) 2004-05-14
AU1043902A (en) 2002-02-25

Similar Documents

Publication Publication Date Title
BR0213380A (en) Alpha-oxisubstituted beta-phenyl propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds
RS51010B (en) Preparation of non-crystalline atorvastatin calcium
DE60102899D1 (en) METHOD FOR SOLVING GLUCAGON-LIKE PEPTID-1 (GLP-1) COMPOUNDS
DE602006009030D1 (en) Process for the preparation of cefoxitin
EA200701581A1 (en) Method of producing cyclohexanone and cyclohexanol
FR2814747B1 (en) PROCESS FOR THE MANUFACTURE OF POLYAMIDES
HUP0300738A2 (en) Method for producing lhrh-peptide salts, their use, and pharmaceutical preparations containing these peptide salts
WO2003029254A1 (en) Process for preparation of tricyclic compounds
EP1336603A4 (en) Method of introducing amino group and method of synthesizing amino acid
EE200100065A (en) Method for the preparation of the calcium salt of zofenopril
EA200701962A1 (en) ADDITIVE SALT TOLPERIZON, METHOD OF THEIR RECEPTION AND THEIR APPLICATION
DK1280812T3 (en) Cyclipostins, process for their preparation and use of the same
Evstigneeva Advances and perspectives of porphyrin synthesis
AU2002233613A1 (en) Process and apparatus for the production of calcium bromide by liquid-liquid extraction
NO20011031D0 (en) Process for Preparation of N-Protected Azetidine-2-Carboxylic Acids (AzeOHs)
EP1065199A3 (en) "Process for the recovery of strong acids from aqueous solution"
AR005903A1 (en) A PROCESS FOR THE PREPARATION OF CHLORHYDRATE IN N (G) -MONOMETHYL-L-ARGININE
ECSP972029A (en) CHEMICAL PROCESS (PROCESS TO PREPARE NG MONOMETHYL-N-ARGININE CHLORHYDRATE)
Tam Synthesis of a symmetric branched peptide. Assembly of a cyclic peptide on a small tetraacetate template
El-Medani Equilibrium studies of binary and ternary complexes of oxytetracycline and amino acid or DNA units
JPS52108923A (en) Process for preparing acidic salt of cis-epoxy succinic acid
TH53587B (en) Chemical compound
MXPA03003069A (en) Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide.
TH45153A (en) Phosphoric salt Acid of aromatic diamine
UA96731C2 (en) Process for preparing cyclohexanone and cyclohexanol

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ZENTARIS GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS AG, DE; ZENTARIS GMBH, DE

FD9A Lapse of provisional protection due to non-payment of fees